EXSIGHT VENTURES
ExSight Ventures is a venture capital firm specializing in early-stage impact investments in innovative ophthalmic diagnostic and treatment solutions. The firm consists of 2 accomplished retinal surgeons and a team of investment professionals that have partnered to address the need for funding early-stage ophthalmic-focused companies. The firm seeks investments in biotechnology, medical devices, pharmaceuticals and software solutions in ophthalmology.
EXSIGHT VENTURES
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical Venture Capital
Founded:
2015-09-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Google Apps For Business Register.com DNS Weebly Hosting
Similar Organizations
Canna Holdings
Canna Holdings invests in products and services within the medical cannabis industry.
Core Clinical
Core Clinical is focuses on being the best medical imaging core laboratory in the industry.
Sanitas Ventures
SaSanitas Ventures is an invesment company that focuses on investing venture capital and private equity on eye care industries.
Spire Bioventures
SPIRE Bioventures is a global player in the digital health/medical device/biotech industry.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-03-01 | DTx Pharma | ExSight Ventures investment in Series B - DTx Pharma | 100 M USD |
| 2020-12-22 | ONL Therapeutics | ExSight Ventures investment in Series B - ONL Therapeutics | 46.9 M USD |
| 2020-06-02 | Re-Vana Therapeutics | ExSight Ventures investment in Seed Round - Re-Vana Therapeutics | 3.25 M USD |
| 2020-01-06 | DTx Pharma | ExSight Ventures investment in Series A - DTx Pharma | 10.6 M USD |
| 2019-07-16 | Trefoil Therapeutics | ExSight Ventures investment in Series A - Trefoil Therapeutics | 28 M USD |
| 2017-05-17 | ONL Therapeutics | ExSight Ventures investment in Series A - ONL Therapeutics | 4.25 M USD |
| 2017-05-01 | LensGen | ExSight Ventures investment in Series A - LensGen | 21 M USD |
| 2017-01-05 | Trefoil Therapeutics | ExSight Ventures investment in Series A - Trefoil Therapeutics | 5.2 M USD |
| 2015-11-12 | RetroSense Therapeutics | ExSight Ventures investment in Series B - RetroSense Therapeutics | 6 M USD |